REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201214:nBw1qsSpKa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 11 December 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,047,743 2.36% 690,560 0.54%
(2) Derivatives (other than options):
365,705 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,413,448 2.65% 1,429,565 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 205.0300 USD
Purchase 2 207.9100 USD
Purchase 2 205.3150 USD
Purchase 2 205.1800 USD
Purchase 4 204.7750 USD
Purchase 4 205.7300 USD
Purchase 10 204.6400 USD
Purchase 13 206.8200 USD
Purchase 18 207.5700 USD
Purchase 19 207.5878 USD
Purchase 19 207.5879 USD
Purchase 25 204.5000 USD
Purchase 44 206.3913 USD
Purchase 62 206.5900 USD
Purchase 98 204.8600 USD
Purchase 100 204.8000 USD
Purchase 100 204.4400 USD
Purchase 100 206.2250 USD
Purchase 132 206.4145 USD
Purchase 142 205.9298 USD
Purchase 165 205.9885 USD
Purchase 183 206.9282 USD
Purchase 200 204.8100 USD
Purchase 220 205.0644 USD
Purchase 220 204.3990 USD
Purchase 224 205.2129 USD
Purchase 276 204.9000 USD
Purchase 314 204.5876 USD
Purchase 488 204.6005 USD
Purchase 498 204.5195 USD
Purchase 570 204.6194 USD
Purchase 603 204.7087 USD
Purchase 629 205.0372 USD
Purchase 668 204.4381 USD
Purchase 1,010 204.7613 USD
Purchase 1,547 204.8266 USD
Purchase 1,792 204.6332 USD
Purchase 1,835 205.6454 USD
Purchase 2,910 204.4000 USD
Purchase 3,262 204.7508 USD
Purchase 3,309 206.4506 USD
Purchase 5,872 204.5372 USD
Purchase 8,312 204.6826 USD
Purchase 13,094 205.4256 USD
Purchase 14,283 204.7658 USD
Purchase 23,920 205.0308 USD
Sale 2 205.1800 USD
Sale 3 207.9100 USD
Sale 13 206.8200 USD
Sale 19 207.5878 USD
Sale 24 204.3050 USD
Sale 25 204.7712 USD
Sale 36 207.5700 USD
Sale 100 204.2700 USD
Sale 100 207.0550 USD
Sale 100 205.7000 USD
Sale 106 204.4433 USD
Sale 138 204.9000 USD
Sale 189 205.0671 USD
Sale 200 204.3150 USD
Sale 200 205.0400 USD
Sale 207 206.7305 USD
Sale 221 207.6970 USD
Sale 500 204.5797 USD
Sale 517 206.3075 USD
Sale 706 204.4474 USD
Sale 1,315 204.3524 USD
Sale 1,390 204.4741 USD
Sale 1,436 206.4576 USD
Sale 1,951 204.4652 USD
Sale 3,699 204.9269 USD
Sale 4,127 206.1471 USD
Sale 4,388 204.4000 USD
Sale 6,154 204.5302 USD
Sale 13,767 205.3280 USD
Sale 17,845 205.1789 USD
Sale 27,780 204.7238 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 14 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201214005346/en/
(https://www.businesswire.com/news/home/20201214005346/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
Announcement